VIR - Vir Biotechnology, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.14
DETAILS
HIGH:
$30.00
LOW:
$18.00
MEDIAN:
$20.00
CONSENSUS:
$21.14
UPSIDE:
130.03%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-01 | SATO VICKI L | director | SELL | 22,000 | $10.05 | $221K |
| 2026-04-29 | De Backer Marianne | director, officer: President and CEO | J-Other | 233,532 | -- | -- |
| 2026-04-06 | De Backer Marianne | director, officer: President and CEO | SELL | 72,559 | $9.16 | $664K |
| 2026-04-01 | SATO VICKI L | director | SELL | 22,000 | $9.07 | $200K |
| 2026-03-23 | Sabatini Brent | officer: SVP, Chief Accounting Officer | SELL | 7,711 | $9.12 | $70K |
| 2026-03-20 | O'Byrne Jason | officer: EVP & Chief Financial Officer | J-Other | 2,500 | -- | -- |
| 2026-03-02 | SATO VICKI L | director | SELL | 21,800 | $9.50 | $207K |
| 2026-03-02 | SATO VICKI L | director | SELL | 200 | $9.98 | $2K |
| 2026-02-24 | SATO VICKI L | director | M-Exempt | 42,377 | $1.49 | $63K |
| 2026-02-24 | SATO VICKI L | director | SELL | 200 | $10.26 | $2K |
| 2026-02-24 | SATO VICKI L | director | SELL | 42,177 | $9.75 | $411K |
| 2026-02-24 | Sabatini Brent | officer: SVP, Chief Accounting Officer | SELL | 1,430 | $9.53 | $14K |
| 2026-02-24 | O'Byrne Jason | officer: EVP & Chief Financial Officer | SELL | 1,634 | $9.53 | $16K |
| 2026-02-24 | Eisner Mark | officer: EVP and Chief Medical Officer | SELL | 1,616 | $9.53 | $15K |
| 2026-02-24 | De Backer Marianne | director, officer: Chief Executive Officer | SELL | 14,762 | $9.53 | $141K |
| 2026-02-24 | de Verneuil Vanina | officer: EVP, General Counsel, Corp Sec | SELL | 3,117 | $9.53 | $30K |
| 2026-02-25 | de Verneuil Vanina | officer: EVP, General Counsel, Corp Sec | SELL | 13,700 | $9.82 | $135K |
| 2026-02-25 | Eisner Mark | officer: EVP and Chief Medical Officer | SELL | 1,889 | $9.82 | $19K |
| 2026-02-22 | O'Byrne Jason | officer: EVP & Chief Financial Officer | A-Award | 55,000 | -- | -- |
| 2026-02-22 | Eisner Mark | officer: EVP and Chief Medical Officer | A-Award | 55,000 | -- | -- |
| 2026-02-23 | Eisner Mark | officer: EVP and Chief Medical Officer | SELL | 2,089 | $7.45 | $16K |
| 2026-02-22 | De Backer Marianne | director, officer: Chief Executive Officer | A-Award | 570,000 | $7.56 | $4.3M |
| 2026-02-22 | De Backer Marianne | director, officer: Chief Executive Officer | A-Award | 285,000 | -- | -- |
| 2026-02-23 | De Backer Marianne | director, officer: Chief Executive Officer | SELL | 19,039 | $7.45 | $142K |
| 2026-02-23 | O'Byrne Jason | officer: EVP & Chief Financial Officer | SELL | 2,089 | $7.45 | $16K |